Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/13167
Title: Lean body mass, body surface area and epirubicin kinetics.
Authors: Cosolo, W C;Morgan, Denis J;Seeman, Ego;Zimet, A S;McKendrick, J J;Zalcberg, John R
Affiliation: Oncology Department, Heidelberg Repatriation Hospital, Victoria, Australia.
Issue Date: 1-Jun-1994
Citation: Anti-cancer Drugs; 5(3): 293-7
Abstract: For a number of cytotoxics, a relationship between efficacy and plasma concentrations has recently been demonstrated. Lean body mass has been demonstrated to be a useful parameter for predicting drug clearance for a number of non-cytotoxic drugs. However, the role of lean body mass in predicting drug clearance for any cytotoxic drug has not been previously reported. Our purpose was to investigate lean body mass as a predictor of epirubicin clearance. Pharmacokinetic studies were performed in 10 patients receiving single agent epirubicin. Although preliminary, this study suggests that lean body should be further evaluated and tested in dose optimization studies.
Internal ID Number: 7919453
URI: http://ahro.austin.org.au/austinjspui/handle/1/13167
URL: http://www.ncbi.nlm.nih.gov/pubmed/7919453
Type: Journal Article
Subjects: Body Mass Index
Body Surface Area
Body Weight.physiology
Epirubicin.blood.pharmacokinetics.toxicity
Humans
Neoplasms.drug therapy.metabolism
Spectrophotometry, Atomic
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.